Target intelligence / Profile preview

Pathogenic bacteria colonization in upper airways

Molecular classification
Other
01

Overview

Colonization of the upper airways by pathogenic bacteria is a prerequisite for many respiratory infections, including pneumonia and otitis media. This process involves attachment of bacteria to the mucosal epithelium, evasion of local immune responses, acquisition of nutrients in a competitive environment, and sometimes biofilm formation. Key bacterial species involved include Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Moraxella catarrhalis. Colonization can be promoted or inhibited by changes in the host microbiota, respiratory viral infections, and immune status. While some interventions can reduce colonization or the risk of progression to disease, "pathogenic bacteria colonization in upper airways" is a broad biological process, not a specific molecular target or receptor.

Other names
Upper airway bacterial colonizationNasopharyngeal colonization by pathogenic bacteriaUpper respiratory tract pathobiont carriage
02

Mechanism of action

Inhibition of bacterial growth; Disruption of bacterial adhesion or biofilm formation; Immunomodulation to enhance host defense

03

Biological functions

Host-pathogen interactionMicrobial adhesionImmune evasionBiofilm formationCompetition with commensal flora
04

Disease associations

InfectionInflammationRespiratory tract infectionsSecondary bacterial pneumonia
05

Safety considerations

Antibiotic resistanceDisruption of commensal microbiota (dysbiosis)Incomplete efficacy of vaccines against colonization versus infection
06

Interacting drugs

Antibiotics (e.g., penicillins, macrolides, cephalosporins; specific drugs depend on the bacterial species)

2 more in the full profile.

07

Biomarkers

Detection of pathogenic bacterial species by PCR or culture from nasopharyngeal swabsInflammatory cytokines in upper airway secretionsAbundance of pathobiont genera (e.g., Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus)

Beyond the preview

Go deeper on Pathogenic bacteria colonization in upper airways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacteria colonization in upper airways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call